Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2019 Jun 12;25(10):2024–2030. doi: 10.1016/j.bbmt.2019.06.004

Figure 1. Post-HCT Pulmonary Complications.

Figure 1.

A) Cumulative Incidence of pneumonitis, diffuse alveolar hemorrhage, and lung GVHD diagnosed by 1 year post-HCT. By 1 year after HCT, the incidence of pneumonitis was 8%, diffuse alveolar hemorrhage was 2%, and lung GVHD was 2%. B) 12-month landmark survival analysis at 100 days, 6 months, and 1 year.